Darwin Knows

Home | Coverage | Agents | Pulse | LogIn | 


Sareum Holdings PLC

Darwin Score-37
TickerSAR
Latest Price0.21 GBP as of close on 04-Jul-2025
3 Month price range0.14 to 0.21 GBP
Market Capitalisation26.55Mn GBP
CountryUnited Great Britain and Northern Ireland
RegionEurope
Economic SectorHealth Care
Business SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryPharmaceuticals
Sub-IndustryPharmaceuticals
Description
Sareum Holdings plc, a clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. The company's lead product is SDC-1801, a TYK2/JAK1 inhibitor which has completed Phase 1 clinical trial for the treatment of autoimmune diseases. It also involves in developing SDC-1802, a TYK2/JAK1 inhibitor, that is in preclinical stage for cancer and cancer-immunotherapy applications; and SRA737, a clinical-stage oral, selective Checkpoint kinase 1 inhibitor, which has completed Phase II clinical trials that targets cancer cell replication and DNA damage repair mechanisms. Sareum Holdings plc was formerly known as Keepfast plc and changed its name to Sareum Holdings plc in July 2004. The company was incorporated in 2004 and is headquartered in Cambridge, the United Kingdom.
See More ...
Company URLhttps://www.sareum.com
See Darwins Full Analysis for Sareum Holdings PLC

Tell Me About

Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Sareum Holdings PLC. Further information and full detail is available when you login.

TMA PartFocus of AnalysisTMA Score
PriceAnalysis of performance, trend, RSI, OBV and moving averages-8
SentimentNews and Candle Patterns. 0
FundamentalsAnalyst Ratings, Valuation and Dividend analysis.-6
FlowInstitutional, Fund and Insider buying and selling.0
ModelsForecast models.-23

Alerts

There are 4 live alerts for Sareum Holdings PLC.


Peer Comparison

There are 4 peers of Sareum Holdings PLC.
Asset NameIndustry GroupPerf(20d)%Asset Score
AstraZeneca PLC (AZN)Pharmaceuticals-4.6-2
GSK plc (GSK)Pharmaceuticals-7.8+6
Hikma Pharmaceuticals PLC (HIK)Pharmaceuticals-5.60
Indivior PLC (INDV)Pharmaceuticals+14.3+35

Share Share on Facebook Share on Twitter Share on Threads Share on LinkedIn


To see complete information on Sareum Holdings PLC or any other assets please login.


If you do not already have an account you can register for a free trial of our service. This will let you explore all the analytical information we have on price, fundamantals, flow, sentiments & models for all the stocks under coverage. You will then be able to compare asset scores and perform a wide range of multi asset analysis such as Market Cycles and Relative Scores.


Follow Us Followon Twitter Share on LinkedIn

©2025 Darwin Knows - All Rights Reserved